B/C 基因型的乙型肝炎病毒在不同丙氨酸氨基转移酶状态下对 Th17、Treg 细胞及其比率的影响

关键词

乙肝 / 基因型 / 丙氨酸氨基转移酶 / Th17 细胞 / Treg 细胞

参考文献

[1] Zamor PJ, Lane AM. Interpretation of HBV serologies[J]. Clin Liver Dis, 2021, 25 (4):689-709.

[2] Pollicino T, Caminiti G. HBV-integration studies in the clinic: Role in the natural history of infection[J]. Viruses, 2021, 13 (3): 368.

[3] Bello KE, Mat Jusoh TNA, Irekeola AA, et al. A recent preva- lence of hepatitis B virus(HBV)genotypes and subtypes in Asia: A systematic review and meta-analysis[J]. Healthcare, 2023, 11 (7):1011-1018.

[4] Gu Y, Li X, Gu L, et al. An immuno-clinic score model for evaluating T cell immunity and predicting early antiviral therapy ef- fectiveness in chronic hepatitis B[J]. Aging, 2020, 12 (24):26063-26079.

[5] Li K, Liu H, Guo T. Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV pa- tients[J]. Clin Res Hepatol Gastroenterol, 2017, 41(4): 399 - 407.

[6] Jose-Abrego A, Roman S, Laguna-Meraz S, et al. Host and HBV interactions and their potential impact on clinical outcomes[J]. Pathogens, 2023, 12(9):1146-1152.

[7] Nicolini LA, Orsi A, Tatarelli P, et al. A global view to HBV chronic infection:Evolving strategies for diagnosis,treatment and prevention in immunocompetent individuals[J]. Int J Environ Res Public Health, 2019, 16(18): 3307.

[8] Hogan S, Page A, Dixit S, et al. HBV prevalence in Sub-conti- nental countries:A systematic review and meta-analysis[J]. PLoS One, 2023, 18(12):e0295670.

[9] Chen J, Li L, Yin Q, et al. A review of epidemiology and clinical relevance of hepatitis B virus genotypes and subgenotypes[J]. Clin Res Hepatol Gastroenterol, 2023, 47(7): 102180.

[10] Wang L, Zeng X, Wang Z, et al. Recent advances in under- standing T cell activation and exhaustion during HBV infection[J]. Virol Sin, 2023, 38(6):851-859.

[11] Wan Z, Zhou Z, Liu Y, et al. Regulatory T cells and T helper 17 cells in viral infection[J]. Scand J Immunol, 2020, 91 (5): e12873.

[12] 高鹏, 雒艳萍. 乙型肝炎病毒在不同丙氨酸氨基转移酶状态下对 Th17、Treg 细胞及其比率的影响[J]. 北京大学学报(医学版), 2022, 54(2):272-277.

[13] Beňová K, Hancková M, Koći K, et al. T cells and their function in the immune response to viruses[J]. Acta Virol, 2020, 64(2): 131-143.

[14] Cui D, Jiang D, Yan C, et al. Immune checkpoint molecules ex- pressed on CD4 ⁺T cell subsets in chronic asymptomatic hepatitis B virus carriers with hepatitis B e antigen-negative[J]. Front Microbiol, 2022, 13: 887408.

[15] Xu J, Zhan Q, Fan Y, et al. Human genetic susceptibility to hepatitis B virus infection[J]. Infect Genet Evol, 2021, 87: 104663.

[16] Revill PA, Tu T, Netter HJ, et al. The evolution and clinical im- pact of hepatitis B virus genome diversity[J]. Nat Rev Gastroen- terol Hepatol, 2020, 17(10):618-634.

[17] Fernandes da Silva C, Keeshan A, Cooper C. Hepatitis B virus genotypes influence clinical outcomes:A review[J]. Can Liver J, 2023, 6(3):347-352.

[18] Likhitsup A, Lok AS. Understanding the natural history of hepati- tis B virus infection and the new definitions of cure and the end- points of clinical trials[J]. Clin Liver Dis, 2019, 23(3): 401 - 416.

基金资助

国家自然科学基金(81800528)